Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
29 hedge funds and large institutions have $10.5M invested in Zosano Pharma Corporation in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
32% more funds holding
Funds holding: 22 → 29 (+7)
14% more capital invested
Capital invested by funds: $9.25M → $10.5M (+$1.26M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Aisling Capital Management
New York
|
+$1.22M |
| 2 |
TI
Telemetry Investments
New York
|
+$238K |
| 3 |
JP Morgan Chase
New York
|
+$108K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$66.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$58.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$142K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$88.2K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$72.9K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$27K |
| 5 |
BlackRock
New York
|
-$9.93K |
ZSAN Hedge Fund Activity: Q4 2019 in Review
29 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2019, worth a combined $10.5M — up 14% from $9.25M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ZSAN positions and 3 closed out — a net gain of 7 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Aisling Capital Management, adding an estimated $1.22M. The largest seller was Alyeska Investment Group, cutting an estimated $142K.
- 29 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2019, up from 22 in Q3 2019.
- Funds reported $10.5M of Zosano Pharma Corporation stock for Q4 2019, up 14% quarter-over-quarter.
- 10 funds opened new Zosano Pharma Corporation positions in Q4 2019 and 3 closed out, a net change of +7 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2019 was Aisling Capital Management, an estimated $1.22M added.
- The largest Zosano Pharma Corporation seller in Q4 2019 was Alyeska Investment Group, an estimated $142K sold.
Based on aggregated 13F filings for Q4 2019.